Enrique Lores - Jul 3, 2023 Form 4 Insider Report for HP INC (HPQ)

Role
President and CEO, Director
Signature
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores
Stock symbol
HPQ
Transactions as of
Jul 3, 2023
Transactions value $
-$2,860,103
Form type
4
Date filed
7/5/2023, 04:34 PM
Previous filing
May 26, 2023
Next filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HPQ Common Stock Options Exercise $1.96M +157K +20.49% $12.47 923K Jul 3, 2023 Direct
transaction HPQ Common Stock Sale -$4.82M -157K -17% $30.69 766K Jul 3, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Employee Stock Option (right to buy) Options Exercise $0 -157K -100% $0.00* 0 Jul 3, 2023 Common Stock 157K $12.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.58-$30.81, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 On October 30, 2015, the reporting person was granted performance contingent options to purchase a total of 470,928 shares. The stock options vested 1/3 annually on each of the anniversaries of the grant date, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date.